Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
8
Bullish
4
Bearish
27
Neutral
8
Bullish
11
Bearish
25
Neutral
0
Bullish
7
Bearish
2
Neutral
8
Bullish
4
Bearish
2
Neutral
8
Bullish
4
Bearish
25
Neutral
0
Bullish
7
Bearish
25
Neutral
0
Bullish
7
Bearish
25
Neutral
0
Bullish
7
Insurance
Life Insurance
1,73,213 Cr
Low Risk
66.6
14.3
15.1
8.6
2,132.90
1,653.00
Sales CAGR
Profit CAGR
ROE
ROCE
SBI Life Insurance Company Ltd (SBILIFE) is currently trading at 1,726.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
SBI Life Insurance Company Limited is a leading Indian life insurer offering individual and group life products, participating and non-participating savings, unit-linked products, pensions and annuities, credit life and protection solutions, distributed through bancassurance, agency, direct and digital channels, while managing a large Assets Under Management franchise to serve both policyholder and shareholder funds. In FY26 SBI Life reported robust scale: gross written premium of INR1,012.9 billion, total new business premium INR425.5 billion, individual-rated new business of INR219 billion, VoNB of INR66.7 billion with a 27.5% margin, assets under management of INR4.9 trillion and embedded value of INR807.9 billion, reflecting broad-based growth across segments. The company is actively rebalancing product mix away from heavy ULIP dependence toward higher-margin non-par, participating and protection products; par and protection recorded strong growth and management targets medium-term APE growth near 14% while maintaining VoNB margins in the mid-to-high twenties. Management signalled prudent governance and transition planning: seeking regulatory forbearance for Ind AS adoption from April 1, 2027, absorbing GST and labour-code impacts into operating metrics, and highlighting persistency improvements, low misselling and high claim settlement ratios as differentiators that support resilient margins and customer trust.
Over the past 52 weeks, SBI Life Insurance Company Ltd has traded between a low of ₹1,653.00 and a high of ₹2,132.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
SBI Life Insurance Company Ltd has a market capitalization of approximately 1,73,212.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
SBI Life Insurance Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 66.60 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,73,212.80 Cr, SBI Life Insurance Company Ltd is classified as a Large Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
SBI Life Insurance Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of SBI Life Insurance Company Ltd is 66.60. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
SBI Life reported PAT of ₹594.37 crore in Q1 FY26, up 14.41% year-on-year from ₹519.52 crore.
The board is scheduled to meet on July 24, 2026 to consider and approve Q1 FY27 results, while some trackers describe the results window as July or August 2026 (TBD).
Nuvama maintained BUY on SBI Life and set a target price of ₹2,390, stating SBILIFE trades at FY27E/FY28E P/EV of 2.0x/1.7x.
SBI Life reported total new business premium of ₹425.5 billion for the year ended March 31, 2026, up 20% year-on-year.